# DESCRIPTION

## BACKGROUND OF THE INVENTION

Biometrics refers to the measurement and statistical analysis of unique physical or behavioral characteristics of individuals, commonly used for identification and health monitoring purposes. These characteristics include physiological signals such as heart rate, respiratory rate, blood pressure, electrodermal activity, and other measurable biological outputs that reflect the internal state of the human body. The field of biometrics has evolved significantly with advances in sensor technology, data processing algorithms, and wireless communication, enabling continuous and non-invasive monitoring of health-related parameters in real-world settings.

The motivation for biometric data monitoring stems from the growing need for proactive and personalized healthcare solutions. Traditional medical diagnostics often rely on episodic assessments conducted in clinical environments, which may fail to capture dynamic physiological changes occurring during daily life. Continuous biometric monitoring allows for the early detection of anomalies, tracking of disease progression, and evaluation of therapeutic interventions outside controlled settings, thereby supporting preventive care strategies and improving patient outcomes.

Physiological processes within the human body—such as cardiac contractions, vascular pulsations, respiration, and autonomic nervous system activity—generate various forms of energy, including electrical potentials, thermal fluctuations, chemical gradients, and mechanical vibrations. These energies manifest as biosignals that can be captured using transducers placed on or near the body surface. Biosignals represent quantifiable manifestations of underlying biological functions and serve as critical inputs for assessing an individual's health status, stress levels, sleep quality, and cardiovascular performance.

Detector devices are instrumental in capturing these biosignals and converting them into digital data suitable for analysis. Such devices typically incorporate sensors capable of detecting minute changes in pressure, motion, temperature, or electromagnetic fields associated with physiological activities. Modern detector technologies include electrocardiography (ECG) electrodes, photoplethysmography (PPG) sensors, accelerometers, gyroscopes, and acoustic microphones, among others. These sensors are increasingly integrated into wearable platforms to enable long-term, ambulatory monitoring without disrupting normal daily routines.

Biometric data analysis involves the application of signal processing techniques, statistical models, and machine learning algorithms to extract meaningful insights from raw biosignal data. This process includes noise reduction, feature extraction, pattern recognition, and classification tasks aimed at identifying specific physiological states or pathological conditions. Advanced analytical methods allow for the derivation of higher-order metrics such as heart rate variability (HRV), respiratory sinus arrhythmia (RSA), and autonomic balance indicators, which provide deeper understanding of an individual’s neurocardiac regulation and overall well-being.

Cardiovascular measurements constitute a central component of biometric monitoring due to their strong correlation with systemic health and disease risk. Key cardiovascular parameters include heart rate (HR), interbeat interval (IBI), HRV, blood pressure, and pulse wave velocity. Accurate and continuous assessment of these metrics enables the detection of arrhythmias, evaluation of autonomic function, and monitoring of responses to physical exertion, emotional stress, or pharmacological treatments. However, existing wearable systems often fall short in delivering medical-grade accuracy, particularly in beat-to-beat IBI estimation under varying physiological conditions.

Contemporary biometric systems face several limitations that hinder their utility in clinical applications. Many consumer-grade wearables suffer from insufficient signal fidelity, susceptibility to motion artifacts, limited battery life, constrained onboard computational resources, and lack of standardization in data interpretation. Additionally, most commercially available devices do not meet regulatory requirements for medical device classification, restricting their use in diagnostic or therapeutic decision-making contexts.

The autonomic nervous system (ANS) plays a pivotal role in regulating involuntary bodily functions, including heart rate, digestion, respiratory rate, and pupillary response. It consists of two primary branches—the sympathetic and parasympathetic nervous systems—that act in opposition to maintain homeostasis. Monitoring ANS activity through biosignal-derived metrics such as HRV provides valuable information about an individual’s stress resilience, recovery capacity, and overall physiological adaptability.

Biofeedback is a technique that uses real-time displays of physiological activity to teach self-regulation of bodily functions. By providing individuals with immediate feedback on their internal states, biofeedback facilitates conscious modulation of ANS activity, promoting relaxation, improved focus, and enhanced emotional regulation. Effective biofeedback requires accurate, low-latency biosignal acquisition and intuitive presentation of relevant physiological metrics.

A closed-loop system integrates sensing, analysis, and responsive intervention in a continuous cycle. In the context of biometric monitoring, such systems detect deviations from baseline physiological states and deliver tailored stimuli—such as auditory cues, haptic feedback, or guided breathing exercises—to guide the user toward a desired state. Closed-loop architectures enhance the efficacy of biofeedback by dynamically adapting interventions based on real-time physiological responses.

Wearable systems have emerged as a dominant platform for biometric data collection due to their portability, ease of use, and potential for unobtrusive long-term monitoring. These systems range from wrist-worn smartwatches and fitness trackers to chest straps, patches, and head-mounted devices. Despite their widespread adoption, many wearable systems remain limited in their ability to capture high-fidelity cardiovascular signals necessary for precise ANS assessment and arrhythmia detection.

## SUMMARY OF THE INVENTION

Wearable biosensing systems offer significant promise for continuous health monitoring but are often constrained by trade-offs between comfort, usability, and signal quality. Current wearable technologies predominantly rely on optical (e.g., PPG) or electrical (e.g., ECG) modalities that may be susceptible to motion artifacts, skin contact issues, or environmental interference, limiting their reliability in real-world scenarios.

The present invention addresses these limitations by introducing an innovative in-ear biosensor system that leverages infrasonic hemodynography (IH) technology for high-fidelity cardiovascular monitoring. Unlike conventional wearables, this system utilizes passive acoustic sensors embedded within earbuds to detect low-frequency pressure fluctuations (<20 Hz) generated by vascular hemodynamics and cardiac mechanical activity. This approach capitalizes on the natural acoustic amplification provided by the occluded ear canal, enhancing signal-to-noise ratio without requiring active transmission or excessive power consumption.

Detector devices within the in-ear biosensor system consist of miniature acoustic pressure sensors strategically positioned inside each earbud to capture IH signals while simultaneously allowing audio playback. These sensors operate in the infrasonic range, ensuring minimal interference with audible sound frequencies and preserving audio quality comparable to commercial-grade earphones.

Limitations of current wearable systems—such as inconsistent skin contact, motion-induced noise, and restricted measurement duration—are mitigated by the anatomical stability of the ear canal and the passive nature of IH signal acquisition. Moreover, the dual-channel configuration (left and right ear) enables stereo signal processing, improving robustness against unilateral artifacts and facilitating spatial discrimination of biosignal sources.

The invention introduces a closed-loop system architecture wherein biosignals are continuously collected, analyzed in real time, and used to inform personalized biofeedback interventions. This system comprises an in-ear biosensor subsystem, a mobile computing interface, and a cloud-based data analysis engine that collaboratively support end-to-end physiological monitoring and adaptive response delivery.

In-ear infrasonic hemodynography (IH) technology represents a novel modality for non-invasive cardiovascular assessment. IH signals originate from mechano-acoustic phenomena associated with heart valve movements, arterial wall vibrations, and pressure pulse propagation through the vasculature into the cranial cavity. These signals exhibit strong temporal correlation with ECG-derived cardiac events and demonstrate high fidelity across repeated heartbeats, even during pronounced physiological perturbations such as resonant breathing or Valsalva maneuvers.

The in-ear biosensor system described herein integrates seamlessly into everyday earbud form factors, enabling extended wear during both daytime and nighttime activities. Its compact design supports continuous, uninterrupted data collection without compromising user comfort or mobility.

The data analysis system employs advanced signal processing pipelines and machine learning models to extract vital signs—including IBI, HR, HRV, and respiratory rate—from raw IH signals. Real-time data collection and analysis occur via secure wireless transmission to cloud infrastructure, where scalable computational resources enable complex analytics beyond the capabilities of local device hardware.

Key advantages of the in-ear biosensor system include: (1) high correlation with gold-standard ECG measurements for IBI and HR; (2) resilience to external auditory stimuli such as music playback; (3) capability to distinguish pathological rhythms like atrial fibrillation (AF) from normal sinus rhythm (SR); (4) compatibility with existing consumer electronics ecosystems; and (5) suitability for longitudinal monitoring in diverse environmental contexts.

IH signals constitute a continuous data stream reflecting beat-to-beat cardiovascular dynamics. Their infrasonic nature ensures compatibility with simultaneous audio output, enabling multimodal functionality that supports both entertainment and health monitoring within a single device.

Closed-loop system features include real-time physiological state identification, comparison against individualized baselines, and delivery of context-aware instructions to modulate autonomic tone. For example, if elevated sympathetic activation is detected, the system may prompt slow-paced breathing or mindfulness exercises to promote parasympathetic engagement.

The data analysis system creates a baseline autonomic nervous system profile for each user by aggregating longitudinal IH-derived metrics under varying conditions. This profile serves as a reference for detecting deviations indicative of stress, fatigue, or emerging pathology.

Current physiological state is identified through real-time mapping of incoming biosignal features onto the established baseline profile. Physiological data—including IBI sequences, HR trends, HRV indices, and inferred respiratory patterns—are synthesized into a multidimensional representation of autonomic balance.

Baseline profiles are constructed by plotting time-series physiological data collected during periods of known stability (e.g., rest, sleep, or controlled breathing). Alternatively, machine learning models trained on historical biosignal datasets can automatically generate personalized baselines that account for circadian rhythms, activity levels, and demographic factors.

External sensor data—such as from wrist-worn PPG devices, chest ECG monitors, or environmental sensors—can be fused with IH signals to enrich baseline construction and improve state classification accuracy. Similarly, user-provided contextual data (e.g., mood logs, medication intake, or dietary records) may be incorporated to refine physiological interpretations.

Presentation of the current physiological state occurs via visual, auditory, or haptic interfaces accessible through a companion mobile application. Users receive actionable insights regarding their autonomic status and guidance on achieving target states aligned with wellness goals or clinical protocols.

Target physiological states—such as relaxed alertness, deep recovery, or focused concentration—are defined based on normative ranges, user preferences, or clinician recommendations. The system instructs individuals to adjust their physiological state through biofeedback prompts designed to shift autonomic balance toward the desired condition.

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention encompasses a comprehensive biosensing and biofeedback platform centered around in-ear infrasonic hemodynography (IH) technology. Its scope extends beyond mere signal acquisition to include real-time analysis, personalized profiling, and closed-loop intervention mechanisms tailored to individual physiology.

For clarity, certain terms are defined as follows: “biosignals” refer to measurable biological outputs reflecting physiological processes; “infrasonic” denotes frequencies below 20 Hz; “hemodynography” describes the recording of vascular and cardiac mechanical activity; and “closed-loop system” indicates an integrated architecture that senses, analyzes, and responds to physiological states in real time.

Figure 1A illustrates an exploded schematic of the IH earbud system, depicting key components including left and right earbuds (1a–d, 1a–f), interconnecting cables (1a–m), controller housing (1a–h), battery (1a–i), and controller board (1a–j). Each earbud contains an infrasonic sensor (1a–d) and speaker (1a–f), enabling concurrent biosignal capture and audio playback.

Components within and/or in communication with the network cloud include application servers, databases, machine learning engines, and user authentication modules. These cloud-resident elements facilitate secure data storage, scalable computation, model training, and remote access by authorized users or healthcare providers.

Computing devices involved in the system include smartphones, tablets, laptops, and dedicated medical terminals. These devices host client applications, manage wireless connectivity, preprocess biosignal data, and render user interfaces for physiological feedback.

Central processing units (CPUs) execute core computational tasks, including signal filtering, feature extraction, and communication protocol handling. Their functions encompass real-time data buffering, encryption, compression, and transmission scheduling to optimize bandwidth usage and latency.

Microprocessors and microcontrollers embedded within the earbud controller board perform low-level sensor interfacing, analog-to-digital conversion, and initial signal conditioning. These components ensure high-fidelity digitization of IH signals prior to wireless transmission.

Application code running on mobile and cloud platforms implements the full biosignal processing pipeline—from raw data ingestion to physiological state inference. Execution occurs within sandboxed environments governed by operating system security policies to protect user privacy and data integrity.

Operating systems manage hardware abstraction, memory allocation, task scheduling, and peripheral interfacing. They provide standardized APIs that enable seamless integration of biosensing functionalities with native device features such as notifications, voice assistants, and health dashboards.

Application programming interfaces (APIs) mediate interactions between software layers, allowing modular development and third-party extensibility. For instance, a wellness app developer could leverage IH-derived HRV metrics via a published API to enhance stress management features.

The in-ear biosensor system comprises dual earbuds equipped with passive infrasonic sensors, a controller unit, and wireless communication circuitry. Earbuds connect physically via flexible cables to the controller, which houses power management, signal processing, and BLE transceiver modules.

User devices—primarily smartphones—run a dedicated application that configures biosensor settings, visualizes physiological data, delivers biofeedback prompts, and manages user accounts. The app communicates bidirectionally with both the earbuds and cloud backend.

Application servers in the cloud orchestrate data routing, model inference, user session management, and alert generation. They interface with electronic health record (EHR) systems to update medical documentation when clinically significant findings are detected.

Medical professionals—including physicians, cardiologists, and mental health practitioners—may access anonymized or consented user data through secure portals to monitor patient progress, adjust treatment plans, or intervene in acute situations.

Connections between system components utilize Bluetooth Low Energy (BLE) for short-range earbud-to-phone links and internet protocols (e.g., MQTT over TLS) for phone-to-cloud communications. Redundant pathways ensure data continuity during transient connectivity losses.

Wireless communications links employ frequency-hopping spread spectrum techniques to minimize interference from co-located RF sources. Data packets are encrypted end-to-end using AES-256 to safeguard sensitive biometric information.

The data analysis system performs multi-stage signal processing: Level 1 captures raw IH waveforms; Level 2 removes audio-induced artifacts; Level 3 classifies signal quality using neural networks; Level 4 detects cardiac events; and Level 5 computes vital signs and autonomic metrics.

Infrasound refers to acoustic waves with frequencies below the threshold of human hearing (<20 Hz). IH biosignals reside in this band and correspond to mechanical vibrations from cardiac and vascular sources transmitted through bone conduction and air-filled cavities to the ear canal.

Biosignals detected by the IH system include pressure fluctuations caused by aortic valve opening/closing, ventricular ejection, and arterial pulse wave reflections. These signals exhibit characteristic morphologies correlated with phases of the cardiac cycle.

Sensors within each earbud are MEMS-based acoustic pressure transducers optimized for infrasonic sensitivity and low self-noise. Their passive operation eliminates the need for external excitation, conserving battery life and reducing electromagnetic interference.

The “stereo effect” arises from differential IH signal acquisition in left and right ears, enabling spatial filtering to suppress common-mode noise (e.g., ambient vibrations) while preserving localized cardiac signatures. Signal fusion algorithms weight contributions from each channel based on real-time quality scores.

Operation of the closed-loop system begins with user authentication via biometric login (e.g., fingerprint or facial recognition). Upon successful verification, biosignal streaming commences, and the data analysis pipeline initiates real-time state assessment.

Transmission of biosignals follows three primary paths: Path A (earbuds → controller → mobile device); Path B (mobile device → cloud server); and Path C (cloud server → EHR/medical professional dashboard). Path C includes HIPAA-compliant audit trails and role-based access controls.

Path B utilizes MQTT over secure TLS tunnels to transmit compressed, timestamped biosignal segments. Message queuing ensures reliable delivery despite intermittent network availability, with automatic retransmission of lost packets.

Path C components include HL7/FHIR-compliant adapters that translate IH-derived findings into standardized clinical formats. Alerts triggered by abnormal rhythms (e.g., AF episodes) are routed to designated care teams with embedded waveform previews and contextual metadata.

The in-ear biosensor system continuously sends biosignals to the data analysis system, which applies convolutional neural networks to identify cardiac cycles, compute IBIs, and derive HRV metrics. Machine learning models trained on large annotated datasets classify rhythm types with >99% sensitivity/specificity.

Authorized personnel can access and update medical records through integrated EHR interfaces. Notifications regarding critical findings—such as prolonged tachycardia or newly detected AF—are automatically logged alongside clinician review timestamps.

Notification messages are delivered via push alerts, SMS, or email depending on urgency and user preferences. Visual content—including trend graphs, spectrograms, and state transition diagrams—is rendered within the mobile app to aid interpretation.

Individuals receive real-time feedback through synthesized voice cues (“Your heart rate is elevated; try slow breathing”) or vibrotactile patterns mapped to autonomic states. Notification messages emphasize actionable steps rather than raw numerical values.

Biosignals are characterized by extracting time-domain features (e.g., peak amplitude, rise time) and frequency-domain descriptors (e.g., spectral entropy, LF/HF ratio). These features feed into ensemble classifiers that label physiological states along dimensions of arousal and valence.

Medical records are updated with each monitoring session, storing IH waveforms, derived metrics, and inferred states in structured databases indexed by patient ID and timestamp. Longitudinal analytics reveal trends in autonomic regulation over weeks or months.

Problems such as persistent arrhythmias or declining HRV are flagged for medical review. Automated reports summarize findings using natural language generation, highlighting deviations from baseline and suggesting follow-up actions.

Feedback to individuals includes guided breathing exercises synchronized to real-time HRV feedback, mindfulness prompts during stress spikes, or sleep hygiene tips based on nocturnal autonomic patterns. Interventions adapt dynamically to user responsiveness.

Auxiliary sensors—such as accelerometers, gyroscopes, or galvanic skin response detectors—may be integrated into future earbud iterations to enhance motion artifact rejection and multimodal state inference.

Communication with mobile devices occurs via BLE 5.0+, supporting high-throughput data streaming with minimal power draw. Companion apps provide firmware updates, calibration routines, and user preference customization.

Closed-loop system 10-2 receives biosignals not only from IH earbuds but also from auxiliary sources like ECG patches, PPG wristbands, or smart clothing. Sensor fusion algorithms reconcile discrepancies and produce consensus physiological estimates.

An ECG system may serve as a ground-truth reference during initial calibration or validation studies. Wrist-worn wearables contribute complementary data on peripheral perfusion and movement intensity.

Eyeglass user devices equipped with EEG or eye-tracking sensors offer additional windows into cognitive load and attentional focus. VR headsets enable immersive biofeedback experiences where virtual environments respond to real-time physiology.

The in-ear biosensor system architecture supports simultaneous IH signal capture and high-fidelity audio playback. Acoustic isolation between infrasonic and audible bands prevents cross-contamination, ensuring both functionalities operate independently.

A biosignal sensitivity study demonstrated that IH waveforms correlate strongly with ECG across diverse breathing conditions. Tachograms derived from IH matched ECG-based IBIs with r=0.988, even during resonant breathing inducing ±150 ms IBI swings.

Power spectra plots reveal dominant IH energy in the 1–10 Hz band, corresponding to cardiac and respiratory harmonics. Low-frequency (LF: 0.04–0.15 Hz) and high-frequency (HF: 0.15–0.4 Hz) HRV bands are reliably resolved, enabling sympathetic/parasympathetic balance estimation.

Existing wearables struggle with motion artifacts and inconsistent contact, whereas IH benefits from the ear canal’s mechanical stability. This makes IH uniquely suited for comprehensive cardiovascular monitoring during activities of daily living.

The closed-loop system for cardiac assessment integrates IH-derived rhythm classification with real-time biofeedback. Upon detecting AF, it may prompt medication adherence checks or emergency contact activation.

Acoustic/vibration sensors in the ear canal may eventually capture speech articulation patterns or jaw movement signatures, enabling novel applications in voice disorder screening or dietary monitoring.

Cloud infrastructure provides elastic storage for petabyte-scale biosignal archives, enabling population-level research and federated learning across institutions while maintaining data sovereignty.

Physiological data—including IBI sequences, HR trends, and inferred ANS states—affect autonomic nervous system interpretation by anchoring abstract metrics to concrete biological events. For example, a sudden IBI shortening followed by rebound lengthening may indicate Valsalva-like strain.

Closed-loop operation accommodates configurations with or without auxiliary sensors. Core functionality remains intact using IH alone, while supplementary inputs refine state resolution in complex scenarios (e.g., distinguishing exercise-induced tachycardia from anxiety).

Baseline autonomic nervous system profiles encapsulate an individual’s typical HRV distribution, circadian HR patterns, and stress recovery kinetics. These profiles evolve gradually through continuous learning from new biosignal streams.

Combining multiple physiological data streams—such as IH, respiration rate, and skin conductance—enables more nuanced ANS state characterization than any single modality alone. Multivariate embeddings capture synergistic interactions between regulatory systems.

Data points from biosignals are translated into physiological states using probabilistic graphical models that map observed features to latent constructs like “relaxed,” “stressed,” or “fatigued.” State boundaries are fuzzy, reflecting the continuum of human experience.

The method of operation begins by monitoring and accessing biosignals from the in-ear system. Raw waveforms undergo preprocessing to remove non-cardiac artifacts before feature extraction.

Physiological data—including IBIs, HR, and HRV—are identified from cleaned biosignals using adaptive peak detection and spectral analysis. These metrics populate the individual’s evolving physiological record.

A baseline ANS profile is created by aggregating high-quality biosignal segments collected during stable conditions. Machine learning models cluster similar states and estimate transition probabilities between them.

Biosignals and baseline profiles are stored securely in encrypted medical records compliant with healthcare data regulations. Access controls restrict viewing rights to authorized entities only.

New biosignals are continuously monitored and accessed for real-time state assessment. Current physiological data—including instantaneous HR and recent HRV—are extracted using the same pipeline applied during baseline creation.

Current physiological state is mapped against the baseline profile using similarity metrics like Mahalanobis distance or cosine similarity in embedded feature space. Significant deviations trigger alerts or biofeedback initiation.

New biosignals and inferred states are appended to the medical record, enriching the longitudinal dataset used for future comparisons. This iterative process refines personalization over time.

Complex mappings between physiological data and states leverage deep learning architectures—such as recurrent neural networks or transformers—that model temporal dependencies and nonlinear interactions across biosignal channels.

Machine learning and deep learning methods underpin all stages of analysis, from signal quality scoring to rhythm classification. Models are retrained periodically using federated learning to preserve privacy while improving generalization.

Creating a baseline profile involves selecting representative biosignal epochs, extracting hundreds of time/frequency-domain features, and applying dimensionality reduction (e.g., PCA or UMAP) to define a compact physiological manifold.

Mapping current data entails projecting live biosignal features onto this manifold and identifying nearest neighbors in the baseline distribution. Anomalies are flagged when distances exceed empirically determined thresholds.

The data analysis system thus creates personalized baselines, maps current states against them, and drives closed-loop interventions accordingly. Biofeedback methods instruct individuals to modulate physiology through paced breathing, cognitive reframing, or postural adjustments.

Individual variability necessitates personalized models; population norms are insufficient for precise state inference. Multiple biosignal instances across contexts (sleep, work, exercise) are obtained and stored to capture intra-individual diversity.

Time-stamped physiological data from external sensors—such as smart scales or glucose monitors—are synchronized with IH streams using NTP-aligned clocks. User-provided data (e.g., journal entries) are aligned via manual tagging or natural language processing.

Various physiological data types—including cortisol levels, oxygen saturation, or core temperature—may be incorporated as they become available from compatible sensors. All inputs are normalized and weighted according to reliability estimates.

Data passes through a unified machine learning model trained specifically on the individual’s historical biosignals. Transfer learning techniques initialize weights from population models before fine-tuning on personal data.

Trained models predict optimal interventions for shifting toward target states. Direct actions include breath pacing; indirect actions involve environmental modifications (e.g., dimming lights) suggested via smart home integrations.

Successful actions are determined by observing subsequent physiological shifts toward the target state. Reinforcement learning updates action-value functions to prioritize effective strategies over time.

Personalized response profiles evolve as the system learns which interventions yield desired outcomes for each user. These profiles inform future biofeedback recommendations with increasing precision.

Applications span healthcare (arrhythmia screening), mental wellness (stress reduction), sports performance (recovery optimization), and human-computer interaction (affective computing). Advertising capabilities leverage inferred emotional states to tailor content ethically and transparently.

Stored baseline ANS profiles enable prediction of impending state transitions—such as pre-syncope or panic onset—allowing preemptive interventions. Music applications curate playlists that entrain HRV toward calm or energized states.

Workspace applications adjust lighting, temperature, or task difficulty based on real-time cognitive load estimates. Social media and dating platforms could verify emotional authenticity during video calls using covert IH monitoring.

Current physiological state and baseline profile are presented visually through interactive dashboards showing deviation heatmaps, trend arrows, and confidence intervals. Target states are displayed alongside recommended actions to bridge the gap.

Individuals receive clear instructions—delivered via preferred modalities—to adjust their physiology toward specified targets. Compliance is incentivized through gamification, progress tracking, and social accountability features.